033270 — Korea United Pharm Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapSuper Stock

Annual cashflow statement for Korea United Pharm, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	28,649	45,275	48,262	32,453	38,308
Depreciation
Amortisation
Non-Cash Items	7,874	14,789	8,472	2,486	9,093
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	174	-5,271	-17,059	-19,415	-7,823
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	44,085	63,782	49,770	26,794	51,136
Capital Expenditures	-12,789	-24,207	-31,309	-21,222	-25,144
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-4,909	-63,695	-24,222	32,923	-15,926
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-17,698	-87,902	-55,531	11,701	-41,069
Financing Cash Flow Items	-73.5	560	375	270	33
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-8,197	-10,586	2,546	-29,458	-3,625
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	20,348	-33,933	-2,982	9,789	6,591